Hepatitis C virus-associated hepatocellular carcinoma after sustained virologic response

The introduction of a direct-acting antiviral (DAA) for patients with hepatitis C virus (HCV) infection, could lead to higher sustained virologic response (SVR) rates with fewer adverse events, and it could shorten the treatment duration relative to the interferon era. Although most recent clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasaki, Reina, Kanda, Tatsuo, Kato, Naoya, Yokosuka, Osamu, Moriyama, Mitsuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323517/
https://www.ncbi.nlm.nih.gov/pubmed/30631394
http://dx.doi.org/10.4254/wjh.v10.i12.898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323517/
https://www.ncbi.nlm.nih.gov/pubmed/30631394
http://dx.doi.org/10.4254/wjh.v10.i12.898

Ejemplares similares